Schneiderman Daniel H Insider Trades

Insider Trading History

Track insider trading activity for Schneiderman Daniel H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Financial Officer
Holding Value $700k 1,129,323 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$949k 1,129,323 shares
$0.84
$0.62
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Financial Officer
Holding Value $5.19k 1,129,323 shares
Last Trade
May 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8.02k 1,129,323 shares
$0.01
$0.00
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Financial Officer
Holding Value $123 26,667 shares
Last Trade
Nov 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57k 26,667 shares
$0.06
$0.00
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Financial Officer
Holding Value $16.5k 26,667 shares
Last Trade
Nov 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$39.2k 26,667 shares
$1.47
$0.62
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Financial Officer
Holding Value $197k 317,266 shares
Last Trade
Oct 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$228k 317,266 shares
$0.72
$0.62
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Financial Officer
Holding Value $1.46k 317,266 shares
Last Trade
Oct 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.84k 317,266 shares
$0.01
$0.00
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Financial Officer
Holding Value $46 10,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$285 15,927 shares
$0.02
$0.00
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Financial Officer
Holding Value $6.2k 10,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 15,927 shares
$8.13
$0.62
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Financial Officer
Holding Value $6.2k 10,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$133k 15,927 shares
$8.34
$0.62
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Financial Officer
Holding Value $46 10,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$285 15,927 shares
$0.02
$0.00
Pasithea Therapeutics - Warrants (11/08/2026)
Pasithea Therapeutics - Warrants (11/08/2026) KTTAW
Chief Financial Officer
Holding Value $1.38k 300,000 shares
Last Trade
Oct 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.9k 300,000 shares
$0.07
$0.00
Pasithea Therapeutics
Pasithea Therapeutics KTTA
Chief Financial Officer
Holding Value $186k 300,000 shares
Last Trade
Oct 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.56M 300,000 shares
$25.20
$0.62
First Wave BioPharma
First Wave BioPharma FWBI
CHIEF FINANCIAL OFFICER
Holding Value $29.6k 10,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$69.7M 10,000 shares
$6,972.00
$2.96
AzurRx BioPharma
AzurRx BioPharma AZRX
CHIEF FINANCIAL OFFICER
Holding Value $34.5k 10,000 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.2k 10,000 shares
$3.52
$3.45
AzurRx BioPharma
AzurRx BioPharma AZRX
CHIEF FINANCIAL OFFICER
Holding Value $121k 35,006 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$287k 35,006 shares
$8.20
$3.45
First Wave BioPharma
First Wave BioPharma FWBI
CHIEF FINANCIAL OFFICER
Holding Value $740k 250,000 shares
Last Trade
Jun 30, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.34M 285,006 shares
$8.20
$2.96
AzurRx BioPharma
AzurRx BioPharma AZRX
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Jun 30, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$287k 35,006 shares
$8.20
$3.45
First Wave BioPharma
First Wave BioPharma FWBI
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Jun 30, 2021 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$2.05M 250,000 shares
$8.20
$2.96
AzurRx BioPharma
AzurRx BioPharma AZRX
CHIEF FINANCIAL OFFICER
Holding Value $1.04M 300,000 shares
Last Trade
Jul 16, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$298k 35,006 shares
$8.50
$3.45
First Wave BioPharma
First Wave BioPharma FWBI
CHIEF FINANCIAL OFFICER
Holding Value $888k 300,000 shares
Last Trade
Jul 16, 2020 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$298k 35,006 shares
$8.50
$2.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up